Qiagen Marseille Issues FY 2013 Revenue Guidance; Sells Ipsogen Inc to Qiagen Inc

Qiagen Marseille announced that it expects a decrease in revenue in fiscal year 2013 due to a transfer price lower than the final customer price list of Qiagen Marseille products and the incidence of revenues generated in December, 2012 by the implementation of the Distribution agreement and, especially other ancillary agreements that were also signed to strengthen synergies between the Company and the Qiagen Group. The Company also announced that it sold its subsidiary Ipsogen Inc. to Qiagen Inc. on January 1, 2013 for a global amount of USD 3.7 million.